Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-09-018877
Filing Date
2009-08-13
Accepted
2009-08-13 17:21:55
Documents
5
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 a10q-063009.htm 10-Q 894643
2 ex31-1.htm EX-31.1 16940
3 ex31-2.htm EX-31.2 16814
4 ex32-1.htm EX-32.1 6202
5 ex32-2.htm EX-32.2 5731
  Complete submission text file 0001140361-09-018877.txt   941950
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 091011398
SIC: 2834 Pharmaceutical Preparations